Loading...

Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines

Cyclin-dependent kinase inhibitor 3 (CDKN3) belongs to the dual-specificity protein phosphatase family, which is hypothesized to regulate cell cycle progression in tumor cells. However, whether CDKN3 is a potential therapeutic target for breast cancer remains to be elucidated. The present in vitro s...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Med Rep
Main Authors: Deng, Miao, Wang, Jianguang, Chen, Yanbin, Zhang, Like, Xie, Gangqiang, Liu, Qipeng, Zhang, Ting, Yuan, Pengfei, Liu, Dechun
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4940103/
https://ncbi.nlm.nih.gov/pubmed/27314680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2016.5401
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!